Sanofi Ev To Sales from 2010 to 2025

SNY Stock  USD 56.90  0.89  1.54%   
Sanofi ADR EV To Sales yearly trend continues to be fairly stable with very little volatility. EV To Sales is likely to outpace its year average in 2025. EV To Sales is the Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue. View All Fundamentals
 
EV To Sales  
First Reported
2010-12-31
Previous Quarter
2.88852504
Current Value
4.17
Quarterly Volatility
0.77185075
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Sanofi ADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanofi ADR's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.3 B, Interest Expense of 603.9 M or Selling General Administrative of 4.9 B, as well as many indicators such as Price To Sales Ratio of 3.91, Dividend Yield of 0.0235 or PTB Ratio of 1.44. Sanofi financial statements analysis is a perfect complement when working with Sanofi ADR Valuation or Volatility modules.
  
Check out the analysis of Sanofi ADR Correlation against competitors.
For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.

Latest Sanofi ADR's Ev To Sales Growth Pattern

Below is the plot of the Ev To Sales of Sanofi ADR over the last few years. It is the Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue. Sanofi ADR's EV To Sales historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sanofi ADR's overall financial position and show how it may be relating to other accounts over time.
Ev To Sales10 Years Trend
Pretty Stable
   Ev To Sales   
       Timeline  

Sanofi Ev To Sales Regression Statistics

Arithmetic Mean3.24
Geometric Mean3.17
Coefficient Of Variation23.84
Mean Deviation0.49
Median3.14
Standard Deviation0.77
Sample Variance0.60
Range3.1704
R-Value(0.26)
Mean Square Error0.59
R-Squared0.07
Significance0.32
Slope(0.04)
Total Sum of Squares8.94

Sanofi Ev To Sales History

2025 4.17
2024 2.89
2022 2.66
2021 3.15
2020 2.9
2019 3.41
2018 3.14

About Sanofi ADR Financial Statements

Sanofi ADR investors use historical fundamental indicators, such as Sanofi ADR's Ev To Sales, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Sanofi ADR. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EV To Sales 2.89  4.17 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Sanofi Stock Analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.